Massive research consortium created in London

Four British hospitals and University College London have forged a £2 billion partnership that will create what's being billed as the largest biomedical research group in Europe. The research consortium is being developed at the urging of the British government, which has been encouraging the formation of science centers focused on the development of new therapies.

According to the Guardian, this new partnership is intended to put London at the forefront of the global drug development world. Together, the group employs more than 3,500 scientists, researchers and consultants.

"By pooling resources and expertise we will be able to produce more world-class research in key areas, including cancer and heart disease, and deliver the benefits more rapidly to patients," said the partners.

- check out the release
- read the article from The Guardian

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.